Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer

Journal of the American College of Surgeons

Volumn 197, Issue 6, 2003, Pages 896-901

  Derossis, Anna M ^a   Fey, Jane V ^a   Cody III, Hiram S ^a   Borgen, Patrick I ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MRI 1026 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; RADIOISOTOPE;

ADULT; AGE DISTRIBUTION; AGED; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CARCINOMA; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; EARLY CANCER; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; AGE; ARTICLE; BREAST TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STANDARD; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 0642303145     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2003.08.005     Document Type: Article

References (26)

1. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 349:1997;1864-1867.
2. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med. 339:1998;941-946.
3. McMasters K.M., Tuttle T.M., Carlson D.J., et al. Sentinel lymph node biopsy for breast cancer a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used . J Clin Oncol. 18:2000;2560-2566.
4. Cabanas R. An approach for the treatment of penile carcinoma. Cancer. 39:1977;456-466.
5. Morton D.L. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 127:1992;392-399.
6. Krag D.N., Weaver D.L., Alex J.C., Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 2:1993;335 - -340.
7. Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:1994;391-401.
8. Albertini J.J., Lyman G.H., Cox C., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 276:1996;1818-1822.
9. Veronesi U., Paganelli G., Viale G., et al. Sentinel lymph node biopsy and axillary dissection in breast cancer results in a large series . J Natl Cancer Inst. 91:1999;368-373.
10. Giuliano A.E., Jones R.C., Brennan M., Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 15:1997;2345-2350.
11. Cody H.S., Fey J., Akhurst T., et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer univariate and multivariate analysis of 966 procedures . Ann Surg Oncol. 8:2001;13-19.
12. Martin R.C.G., Derossis A., Fey J., et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery. 130:2001;432-438.
13. Derossis A.M., Fey J., Yeung H., et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 193:2001;473-478.
14. National Institutes of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. 1998. Available at: www.nhlbi.nih.gov/guidelines/obesity/practgde.htm.
15. Centers for Disease Control, National Center for Health Statistics. National health interview survey, 1997. Available at: www.cdc.gov/nchs/products/ pubs/pubd/hestats/3and4/overweight.htm.
16. Cox C.E., Pendas S., Cox J.M., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 227:1998;645-651.
17. Health implications of obesity. (NIH Consensus Panel). Ann of Intern Med 1985;103:1073-1077.
18. Ingram D.M., Huang H.Y., Catchpole B.N., Roberts A. Do big breasts disadvantage women with breast cancer. Aust N Z J Surg. 59:1989;115-117.
19. Hebert J.R., Augustine A., Barone J., et al. Weight, height, and body mass index in the prognosis of breast cancer early results of a prospective study . Int J Cancer. 42:1988;315-318.
20. Werner R.S., McCormick B., Petrek J.A., et al. Arm edema in conservatively managed breast cancer obesity is a major predictive factor . Radiology. 180:1991;177-184.
21. Larson D., Weinstein M., Goldberg I., et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 12:1986;1575-1582.
22. Petrek J.A., Senie R.T., Peters M., Rosen P.P. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 92:2001;1368-1377.
23. Ingram D., Nottage E., Ng S., et al. Obesity and breast disease. Cancer. 64:1989;1049-1053.
24. Trentham-Dietz A., Newcomb P.A., Egan K.M., et al. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control. 11:2000;533-542.
25. Morrow M., Rademaker A.W., Bethke K.P., et al. Learning sentinel node biopsy results of a prospective randomized trial of two techniques . Surgery. 126:1999;714-722.
26. Cox C.E., Dupont E., Whitehead G.F., et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 8:2002;88-91.